Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2016 07:00 ET | Source: CoLucid Pharmaceuticals, Inc

CoLucid Pharmaceuticals and IMS Health Publish White Paper to Address Migraine Market Misperceptions

CAMBRIDGE, MA, Jan. 05, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate,...